HK40086830A - 2-(2，4，5-取代苯氨基)嘧啶衍生物 - Google Patents

2-(2，4，5-取代苯氨基)嘧啶衍生物 Download PDF

Info

Publication number
HK40086830A
HK40086830A HK42023076056.3A HK42023076056A HK40086830A HK 40086830 A HK40086830 A HK 40086830A HK 42023076056 A HK42023076056 A HK 42023076056A HK 40086830 A HK40086830 A HK 40086830A
Authority
HK
Hong Kong
Prior art keywords
methyl
mmol
amino
mixture
methoxy
Prior art date
Application number
HK42023076056.3A
Other languages
English (en)
Inventor
Sam Butterworth
Richard Andrew Ward
Maurice Raymond Verschoyle Finlay
Vasantha Krishna Kadambar
Chandrasekhara Reddy Chintakuntla
Andiappan Murugan
Claudio Edmundo Chuaqui
Heather Marie Redfearn
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK40086830A publication Critical patent/HK40086830A/zh

Links

HK42023076056.3A 2011-07-27 2023-07-17 2-(2，4，5-取代苯氨基)嘧啶衍生物 HK40086830A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161512061P 2011-07-27
US201261591363P 2012-01-27

Publications (1)

Publication Number Publication Date
HK40086830A true HK40086830A (zh) 2023-09-01

Family

ID=

Similar Documents

Publication Publication Date Title
US20240182441A1 (en) 2-(2,4,5-substituted-anilino)pyrimidine compounds
HK40086830A (zh) 2-(2，4，5-取代苯氨基)嘧啶衍生物
HK40082765A (zh) 作为egfr调谐子的2-(2，4，5-取代苯胺)嘧啶化合物
HK1256370B (zh) 2-(2，4，5-取代苯胺)嘧啶衍生物作为egfr调节子用於治疗癌症
AU2015261672B2 (en) 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer
AU2013204962B2 (en) Polymorphic form of a mesylate salt of n-(2-{2-dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
HK1221216B (zh) 2-(2，4，5-取代苯胺)嘧啶衍生物作为egfr调谐子用於治疗癌症
HK1192549B (zh) 2-(2，4，5-取代苯胺)嘧啶衍生物作为egfr调谐子用於治疗癌症
NZ617393B2 (en) 2-(2,4,5-substituted-anilino)pyrimidine derivatives as egfr modulators useful for treating cancer